Rationally designed multitarget agents against inflammation and pain.
about
Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular DiseasesDual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain ManagementRecent advances in the search for novel 5-lipoxygenase inhibitorsThe Anti-Inflammatory Effects of Lipoxygenase and Cyclo-Oxygenase Inhibitors in Inflammation-Induced Human Fetal Glia Cells and the Aβ Degradation Capacity of Human Fetal Astrocytes in an Ex vivo AssayTargeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.Synthesis and Biological Evaluation of New Phthalazinone Derivatives as Anti-Inflammatory and Anti-Proliferative Agents.Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective.Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors.Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trialBasal and inducible anti-inflammatory epoxygenase activity in endothelial cells.Inhibitors of the arachidonic acid cascade: interfering with multiple pathways.Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase.Exploring the chemical space of multitarget ligands using aligned self-organizing maps.Enhanced anti-inflammatory potential of cinnamate-zinc layered hydroxide in lipopolysaccharide-stimulated RAW 264.7 macrophages.Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14.Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments.Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis
P2860
Q26767400-E302B6BE-CC79-417E-816F-A09F4ECD7232Q28067493-2057E267-488A-4872-8259-B9BA3749EBDFQ28296738-47954AD8-B8FC-4939-A131-ED98F82F86DBQ33736575-E404C8A7-F21D-47D1-852B-19791C3AA425Q35070934-37A144E8-2200-464B-90F3-B23B75EA0EF6Q35883512-18E16C62-628E-43F5-B26D-49E662AB37B3Q36097620-0181938A-E5F7-4A34-8BB4-E68C72BFD8E4Q36379542-67A21098-3A6F-47FF-959F-14BC098D2D05Q37363551-D29A7F93-AE44-4530-846D-81C2697D95B4Q37709772-2E78EE81-DB55-4375-9C41-8E1FD0D6FFE1Q38135433-62A3533A-AB4C-43D2-9A20-EC764EF930F8Q38550350-CB52028B-F2AE-426A-AB34-4717F004C99BQ38558587-7B824550-DE9F-4EBC-A0BD-AC70E5EF55C3Q38723598-2F691469-53A9-49E6-B68C-33EF731CE060Q39775374-CEDFEC92-B826-421F-B192-D1C30788B062Q40463138-4EF899F2-A533-4914-830B-ED1091C1B0D8Q41518288-D1AE62BB-C4F8-44D8-B574-870CC3264E3DQ41527063-031B10DD-7895-4527-AD75-FED7D7C4F307Q46374706-DE9718E8-096D-4AFE-A893-6E9A81781299Q46726564-7412A81D-704E-488E-B44F-45D0DFE584BFQ51025124-DDF48FE4-57C5-4659-8CF7-766890A1C2DEQ53753660-4C159A34-A5CA-473C-8849-3AA9BBA50B75Q59033875-7C1EA3A3-511F-446D-A9E4-A998F9581BD9
P2860
Rationally designed multitarget agents against inflammation and pain.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rationally designed multitarget agents against inflammation and pain.
@ast
Rationally designed multitarget agents against inflammation and pain.
@en
type
label
Rationally designed multitarget agents against inflammation and pain.
@ast
Rationally designed multitarget agents against inflammation and pain.
@en
prefLabel
Rationally designed multitarget agents against inflammation and pain.
@ast
Rationally designed multitarget agents against inflammation and pain.
@en
P2093
P2860
P1476
Rationally designed multitarget agents against inflammation and pain.
@en
P2093
A T Wecksler
B D Hammock
P2860
P304
P356
10.2174/0929867311320130013
P577
2013-01-01T00:00:00Z